Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127439481 | 12743948 | 1 | I | 20160906 | 20160914 | 20160914 | EXP | IT-MINISAL02-369935 | IT-MYLANLABS-2016M1038118 | MYLAN | 0.00 | Y | 0.00000 | 20160914 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127439481 | 12743948 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | UNK | U | U | 76288 | |||||||||
127439481 | 12743948 | 2 | SS | OLANZAPINA TEVA | OLANZAPINE | 1 | UNK | N | U | 0 | FILM-COATED TABLET | ||||||||
127439481 | 12743948 | 3 | SS | LORAZEPAM. | LORAZEPAM | 1 | U | U | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127439481 | 12743948 | 1 | Psychotic disorder |
127439481 | 12743948 | 2 | Psychotic disorder |
127439481 | 12743948 | 3 | Psychotic disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127439481 | 12743948 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127439481 | 12743948 | Adjustment disorder | |
127439481 | 12743948 | Anxiety | |
127439481 | 12743948 | Disturbance in attention | |
127439481 | 12743948 | Learning disorder | |
127439481 | 12743948 | Listless | |
127439481 | 12743948 | Memory impairment | |
127439481 | 12743948 | Social problem |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |